Published in Toxins (Basel) on December 02, 2015
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet (2005) 9.78
Mass spectrometry and protein analysis. Science (2006) 8.05
Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed Mass Spectrom (1984) 7.52
Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods (2012) 4.93
Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun (1993) 3.36
Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr Top Microbiol Immunol (1992) 3.03
Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples. Infect Immun (1993) 2.47
Mass spectrometry based targeted protein quantification: methods and applications. J Proteome Res (2009) 2.20
Enterobacter cloacae producing a Shiga-like toxin II-related cytotoxin associated with a case of hemolytic-uremic syndrome. J Clin Microbiol (1996) 1.91
The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Infect Immun (1994) 1.70
Shiga toxin--an expanding role in the pathogenesis of infectious diseases. J Infect Dis (1985) 1.68
Shiga toxin subtypes display dramatic differences in potency. Infect Immun (2011) 1.63
Bacteriophage lambda: alive and well and still doing its thing. Curr Opin Microbiol (2001) 1.29
Lytic and lysogenic infection of diverse Escherichia coli and Shigella strains with a verocytotoxigenic bacteriophage. Appl Environ Microbiol (2001) 1.27
Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice. Infect Immun (2008) 1.20
Specificity of PCR and serological assays in the detection of Escherichia coli Shiga toxin subtypes. Appl Environ Microbiol (2011) 1.07
Comparative genomics of Shiga toxin encoding bacteriophages. BMC Genomics (2012) 1.07
Human serum amyloid P component protects against Escherichia coli O157:H7 Shiga toxin 2 in vivo: therapeutic implications for hemolytic-uremic syndrome. J Infect Dis (2006) 1.04
Serum amyloid P component is the Shiga toxin 2-neutralizing factor in human blood. J Biol Chem (2001) 1.00
Evaluation of three commercially available enzyme-linked immunosorbent assay kits for detection of Shiga toxin. J Food Prot (2009) 0.98
Mass spectrometric detection of attomole amounts of the prion protein by nanoLC/MS/MS. J Am Soc Mass Spectrom (2007) 0.97
Isolation and identification of an Enterobacter cloacae strain producing a novel subtype of Shiga toxin type 1. J Clin Microbiol (2014) 0.95
Molecular basis of differential B-pentamer stability of Shiga toxins 1 and 2. PLoS One (2010) 0.95
A polyclonal antibody based immunoassay detects seven subtypes of Shiga toxin 2 produced by Escherichia coli in human and environmental samples. PLoS One (2013) 0.92
Purification and characterization of Shiga toxin 2f, an immunologically unrelated subtype of Shiga toxin 2. PLoS One (2013) 0.90
Sensitive detection of Shiga Toxin 2 and some of its variants in environmental samples by a novel immuno-PCR assay. Appl Environ Microbiol (2011) 0.90
Serum amyloid P component binding to Shiga toxin 2 requires both a subunit and B pentamer. Infect Immun (2003) 0.89
Stability of the homopentameric B subunits of shiga toxins 1 and 2 in solution and the gas phase as revealed by nanoelectrospray fourier transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom (2005) 0.87
Affinities of Shiga toxins 1 and 2 for univalent and oligovalent Pk-trisaccharide analogs measured by electrospray ionization mass spectrometry. Glycobiology (2007) 0.87
Instability of a Shiga toxin type 2 gene in Enterobacter cloacae. J Clin Microbiol (1997) 0.85
Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1. Rapid Commun Mass Spectrom (2005) 0.85
Assembly and stability of the shiga toxins investigated by electrospray ionization mass spectrometry. Biochemistry (2009) 0.85
The observation of multivalent complexes of Shiga-like toxin with globotriaoside and the determination of their stoichiometry by nanoelectrospray Fourier-transform ion cyclotron resonance mass spectrometry. Glycobiology (2001) 0.82
Induction and identification of disulfide-intact and disulfide-reduced β-subunit of Shiga toxin 2 from Escherichia coli O157:H7 using MALDI-TOF-TOF-MS/MS and top-down proteomics. Analyst (2011) 0.82
Top-down proteomic identification of furin-cleaved α-subunit of Shiga toxin 2 from Escherichia coli O157:H7 using MALDI-TOF-TOF-MS/MS. J Biomed Biotechnol (2011) 0.81
New Stx2e Monoclonal Antibodies for Immunological Detection and Distinction of Stx2 Subtypes. PLoS One (2015) 0.80
Safe and effective means of detecting and quantitating Shiga-like toxins in attomole amounts. Anal Chem (2014) 0.79
Oxidation of methionine 216 in sheep and elk prion protein is highly dependent upon the amino acid at position 218 but is not important for prion propagation. Biochemistry (2013) 0.77
Multiplex detection of protein toxins using MALDI-TOF-TOF tandem mass spectrometry: application in unambiguous toxin detection from bioaerosol. Anal Chem (2012) 0.77
Analysis of Vero toxins 1 and 2 by high-performance liquid chromatography/electrospray ionization mass spectrometry. J Mass Spectrom (1997) 0.76